Objectives

After participating in this educational activity, attendees should be able to:
1. Understand impact of Immuno-oncologics (IO) on px for patients with solid tumors
2. Recognize symptoms of most common life-threatening IO adverse events (AEs)
3. Know the basic approach to managing IO AEs

Faculty

Speaker Name
Dawn J. Brooks, MD, PhD
Adult Hematology/Oncology
UMMS - Baystate Medical Center
 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.